A 28-Day, Polysomnographic and Subjective Assessment of Vestipitant (15mg/day) for the Treatment of Primary Insomnia in Adult Outpatients

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-006345-72

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To compare the efficacy of oral vestipitant (15mg/day) with placebo after 4 weeks of nightly treatment in adult outpatients diagnosed with primary insomnia, as determined objectively by polysomnography (PSG).


Critère d'inclusion

  • Primary Insomnia in Adult Outpatients

Liens